UPDATE : Monday, April 22, 2019
OECD guideline OKs Korean-developed eye irritation test by Lee Hye-seon 2019-04-22 15:33
How to improve treatment guidelines for dyslipidemia? by Kim Yun-mi 2019-04-22 14:50
Gene therapies’ potentials, challenges explained by Jeong Sae-im 2019-04-22 11:46
Seoul Medical Center to export public healthcare platform to Turkmenistan by Lee Han-soo 2019-04-19 17:48
‘Darzalex as another weapon against multiple myeloma’ by Park Gi-taek 2019-04-19 15:39
Fine dust can increase risk of hypertension in people with abdominal obesity by Lee Han-soo 2019-04-19 15:28
Why is TissueGene CEO silent about Invossa mislabeling? by Jeong Sae-im 2019-04-19 14:37
[Special]‘K-Medi’s overseas advance will contribute to health of global citizens’ by Kwak Sung-sun 2019-04-19 14:22
JVM to supply pharmaceutical packaging machine to Russia by Lee Han-soo 2019-04-19 14:09
Dong-A to export birth control pill to Vietnam by Lee Han-soo 2019-04-19 13:41
Diabetic patients have higher risk of suffering from other illnesses by Lee Han-soo 2019-04-18 16:02
CJ HealthCare’s new gastric acid blocker K-Cab sold ₩ 1.5 billion in March by Jeong Sae-im 2019-04-18 15:27
‘No need to reduce number of drugs for triple-drug therapy to treat HIV’ by Kim Yun-mi 2019-04-18 15:20
Novartis’ new macular degeneration drug has to compete against colon cancer drug Avastin. Why? by Kim Yun-mi 2019-04-18 14:42
‘How Korean pharma companies can succeed in US’ by Lee Han-soo 2019-04-18 14:41
Kolon desperate to keep Invossa license amid suspicion of data fabrication by Lee Hye-seon 2019-04-18 11:16
IVI-led consortium wins Fleming Fund's grant by Lee Han-soo 2019-04-18 11:15
Severance Hospital succeeds in combined lung-liver transplant by Lee Han-soo 2019-04-17 18:00
Small drugmakers celebrate export deals worth ₩18.3 billion by Kwak Sung-sun 2019-04-17 17:20
THAAD backlash almost over: Chinese patients to Korea up 18 % by Kwak Sung-sun 2019-04-17 16:00
Back to Top